To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)
NCT00482196 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 173
Last updated 2015-04-28
Summary
To study different doses of MK0493 for safety, efficacy and tolerability in obese patients.
Conditions
Interventions
- DRUG
-
MK0493
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2006-03-31
- Completion
- 2006-03-31
More Related Trials
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
NCT01614782 ·Status: TERMINATED ·Phase: PHASE1
-
An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)
NCT00642993 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study to Evaluate BMS-830216 in Healthy Subjects
NCT00878020 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)
NCT01088711 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
NCT06054698 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption
NCT04926051 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase I Study to Investigate the ADME of KD101
NCT02819934 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT04144049 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
NCT06396429 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NGM395 in Adult Participants
NCT04187339 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
NCT04116632 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
NCT02835235 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
NCT02431442 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of SHR20004(Noiiglutide ) on Body Weight in Obese Subjects Without Diabetes
NCT04799327 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
NCT04839237 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
NCT01872182 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of ZT002 Injection in Participants With Overweight or Obesity
NCT06371326 ·Status: COMPLETED ·Phase: PHASE1